Related references
Note: Only part of the references are listed.Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
A. Bourrier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Total and partial cancer prevalence in the adult French population in 2008
Marc Colonna et al.
BMC CANCER (2015)
Inflammatory Bowel Disease Is Associated With an Increased Risk of Melanoma: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study
Cloe Charpentier et al.
GUT (2014)
Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: A case-control observational study based on registry data
Urpo Nieminen et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study
Tine Jess et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients With Ulcerative Colitis: A Case-Control Study
David T. Rubin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Epidemiology of inflammatory bowel diseases: New insights from a French population-based registry (EPIMAD)
Corinne Gower-Rousseau et al.
DIGESTIVE AND LIVER DISEASE (2013)
Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study
Nabeel Khan et al.
GASTROENTEROLOGY (2013)
Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease
Laurent Beaugerie et al.
GASTROENTEROLOGY (2013)
Adenomas in Patients with Inflammatory Bowel Disease Are Associated with an Increased Risk of Advanced Neoplasia
Fiona D. M. van Schaik et al.
INFLAMMATORY BOWEL DISEASES (2013)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
The Risk of Inflammatory Bowel Disease-Related Colorectal Carcinoma Is Limited: Results From a Nationwide Nested Case-Control Study
Judith E. Baars et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2011)
Epidemiology and Natural History of Inflammatory Bowel Diseases
Jacques Cosnes et al.
GASTROENTEROLOGY (2011)
Colitis-associated cancer: the dark side of inflammatory bowel disease
Silvio Danese et al.
GUT (2011)
IBD in the elderly population: Results from a population-based study in Western Hungary, 1977-2008
Peter Laszlo Lakatos et al.
JOURNAL OF CROHNS & COLITIS (2011)
Risk of Extra-Intestinal Cancer in Inflammatory Bowel Disease: Meta-Analysis of Population-Based Cohort Studies
Natalia Pedersen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Millie D. Long et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
MOLECULAR ORIGINS OF CANCER DNA Damage, Aging, and Cancer
Jan H. J. Hoeijmakers
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
J. Satsangi et al.
GUT (2006)
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
T Bongartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease
C Canavan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
E Baecklund et al.
ARTHRITIS AND RHEUMATISM (2006)
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial
SB Hanauer et al.
GASTROENTEROLOGY (2006)
Infliximab for induction and maintenance therapy for ulcerative colitis
P Rutgeerts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Inflammatory bowel diseases: clinical update of practical guidelines
A Viscido et al.
NUCLEAR MEDICINE COMMUNICATIONS (2005)
Infliximab maintenance therapy for fistulizing Crohn's disease
BE Sands et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
M Rutter et al.
GASTROENTEROLOGY (2004)
Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999)
F Molinié et al.
GUT (2004)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
